Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
B 12.0 0.42% 0.05
HOOK closed up 0.93 percent on Monday, March 1, 2021, on 1.33 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical HOOK trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.42%
Crossed Above 20 DMA Bullish 1.35%
Crossed Above 50 DMA Bullish 1.35%
Outside Day Range Expansion 1.35%
Fell Below 20 DMA Bearish 3.00%
Fell Below 50 DMA Bearish 3.00%
Cup with Handle Other 3.00%
Crossed Above 20 DMA Bullish 2.04%
Crossed Above 50 DMA Bullish 2.04%
Cup with Handle Other 2.04%
Older End-of-Day Signals for HOOK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support 14 minutes ago
Up 1% about 1 hour ago
1.5x Volume Pace about 2 hours ago
Down 1% about 23 hours ago
60 Minute Opening Range Breakdown about 24 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

HOOKIPA Pharma Inc. Description

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Cancers Hepatitis B Immunodeficiency Transplantation Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant

Is HOOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.68
52 Week Low 5.8
Average Volume 133,173
200-Day Moving Average 10.81
50-Day Moving Average 11.65
20-Day Moving Average 11.87
10-Day Moving Average 11.91
Average True Range 0.63
ADX 11.24
+DI 19.63
-DI 18.26
Chandelier Exit (Long, 3 ATRs ) 10.80
Chandelier Exit (Short, 3 ATRs ) 11.88
Upper Bollinger Band 12.42
Lower Bollinger Band 11.31
Percent B (%b) 0.57
BandWidth 9.35
MACD Line 0.05
MACD Signal Line 0.07
MACD Histogram -0.0242
Fundamentals Value
Market Cap 261.12 Million
Num Shares 21.9 Million
EPS -4.91
Price-to-Earnings (P/E) Ratio -2.43
Price-to-Sales 15.72
Price-to-Book 3.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.70
Resistance 3 (R3) 12.70 12.45 12.58
Resistance 2 (R2) 12.45 12.26 12.45 12.54
Resistance 1 (R1) 12.20 12.14 12.08 12.20 12.49
Pivot Point 11.95 11.95 11.89 11.95 11.95
Support 1 (S1) 11.70 11.76 11.57 11.70 11.41
Support 2 (S2) 11.45 11.64 11.45 11.36
Support 3 (S3) 11.20 11.45 11.32
Support 4 (S4) 11.20